Cas:188875-36-7 1-(3-chloropropoxymethyl)-2-methoxybenzene manufacturer & supplier

We serve Chemical Name:1-(3-chloropropoxymethyl)-2-methoxybenzene CAS:188875-36-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(3-chloropropoxymethyl)-2-methoxybenzene

Chemical Name:1-(3-chloropropoxymethyl)-2-methoxybenzene
CAS.NO:188875-36-7
Synonyms:3-(2-Methoxybenzyloxy)propylchloride;2-methoxybenzyl 3-chloropropyl ether;2-AMINO-6-FLUORO-4-HYDRAZINOPYRIMIDINE;1-(3-Chloro-propoxymethyl)-2-methoxy-benzene
Molecular Formula:C11H15ClO2
Molecular Weight:214.68900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:18.46000
Exact Mass:214.07600
LogP:2.84070

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-(2-Methoxybenzyloxy)propylchloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3-Chloro-propoxymethyl)-2-methoxy-benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-Chloro-propoxymethyl)-2-methoxy-benzene Use and application,2-methoxybenzyl 3-chloropropyl ether technical grade,usp/ep/jp grade.


Related News: Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. 1-(3-chloropropoxymethyl)-2-methoxybenzene manufacturer As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 1-(3-chloropropoxymethyl)-2-methoxybenzene supplier As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. 1-(3-chloropropoxymethyl)-2-methoxybenzene vendor Although bird flu poses more of a danger to poultry than humans �� it is not easily transmissible among people �� the World Health Organization has called on countries to be on guard because the virus can mutate into a transmissible form and has the potential to cause a pandemic. 1-(3-chloropropoxymethyl)-2-methoxybenzene factory Pharmaceutical intermediates and APIs belong to the fine chemical industry.